Home Markets Experimental Lilly drug cuts genetic heart disease risk factor by 94% in trial Experimental Lilly drug cuts genetic heart disease risk factor by 94% in trial Andrew M Mar 30, 2025 comments off Tweet on Twitter Share on Facebook Google+ Pinterest Original source: https://www.investing.com/news/stock-market-news/experimental-lilly-drug-cuts-genetic-heart-disease-risk-factor-by-94-in-trial-3956229 Cardiovascular disease Experimental Lilly drug cuts genetic heart disease Market Updates www.investing.com/news/stock-market-news/experimental-lilly-drug-cuts-genetic-heart-disease-risk-factor-by-94-in-trial-3956229